Applied Therapeutics Inc (APLT)

$0.44 -0.01 (-1.66%)
Market Cap 63.39M
Revenue (ttm) 460,000.00
Net Income (ttm) -105.62M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -22,960.87%
Debt to Equity Ratio 0.00
Volume 449,824
Avg Vol 1,209,126
Day's Range N/A - N/A
Shares Out 144.01M
Stochastic %K 16%
Beta 2.06
Analysts Sell
Price Target $3.17

Company Profile

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, an...

Industry: Biotechnology
Sector: Healthcare
Phone: 212 220 9226
Address:
545 Fifth Avenue, Suite 1400, New York, United States
Gravy94
Gravy94 Sep. 11 at 5:06 PM
$APLT just tell me Nancy Pelosi’s husband is invested in it, and I’ll bet the house!
1 · Reply
5xStarTrader
5xStarTrader Sep. 11 at 4:13 PM
$APLT The MMs are loading up ahead of the pending FDA news, bc they know as much as we do, or more, from their “colleagues-for-hire” at the FDA, on the imminent positive news (after all, it’s not like Congress is concerned about insider trading.) So as a MM, how do you get sellers? You do it by pulling out your Bids and dropping the stock price, while blockading the Ask with unlimited counterfeit shares, in order to collect those millions of shares shares without running up the share price. Just remember, 100% of patients in the trial opted to continue taking the drug bc of their experience of significant improvements in quality of life.
1 · Reply
CAMDENBEER
CAMDENBEER Sep. 10 at 2:30 PM
$APLT you losers could own Oracle, - orcl - up $95 points today. or you can own this APLT trash. and wait for the chapter 11 and delisting.
2 · Reply
Jasko563
Jasko563 Sep. 10 at 11:40 AM
$APLT bears in this thread are weird .. 99% of them don’t short this or don’t short at all . Yet they hang around here. Like why !? brother we trade penny stocks we don’t need your financial advice . A lot of us are here to flip plays not hold for years nor should you. lol I got just enough invested in this that I don’t care if I loose once my stop loss gets hit . Now if you are shorting this then good for you let’s battle it out and see who wins short term 😊 GL to all bulls and bears & fuc* all the penny stock financial advisers , you guys are goofy
1 · Reply
Moondogshouse
Moondogshouse Sep. 9 at 8:09 PM
$APLT Just typical MM trading the past 20 trading days. Add in low 40’s sell low 50’s. Great returns. Gonna be same pattern for the next 20 days. 20 days ago 42.2. 10 days later .55. 10 days later low of .425. MM and day traders love this.
0 · Reply
CAMDENBEER
CAMDENBEER Sep. 9 at 4:59 PM
$APLT if you want to know why APLT is sinking... just look at Level 2 quotes. lots of big sell limit orders. very few bids.
1 · Reply
Pengwinn
Pengwinn Sep. 9 at 4:01 PM
$APLT This company is a real disaster
2 · Reply
Pengwinn
Pengwinn Sep. 9 at 3:55 PM
$APLT It will retest 0.29. Extremely dangerous. A triple bottom is extremely likely.
0 · Reply
DJW009
DJW009 Sep. 9 at 3:23 PM
$APLT Just playng with some numbers, AT-007 SORD-CMT could treat 7,000 (US and EU) patients annually. That is an estimated revenue of $500M (peak annually). Plus estimated another $100M for PMM2-CDG, plus some for leasing out their drug AT-001 $10M-$20M (?). That's $610M or more. With 144.01M shares outstanding, plus 75M (potentially) more = 219.1M shares outstanding. $610M/219.01 shares = 2.785 x 2.5 multiplier (2 to 4 is normal) = $6.93 per share.
2 · Reply
DJW009
DJW009 Sep. 9 at 2:27 PM
$APLT Sponsored assay for CMT-SORD was launched in July 2025 to help identify patients with CMT-SORD to treat for their drug. This shows confidence in proceeding forward with their FDA meeting.
0 · Reply
Latest News on APLT
Applied Therapeutics Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 5:11 PM EDT - 4 weeks ago

Applied Therapeutics Reports Second Quarter 2025 Financial Results

Applied Therapeutics Announces Key Leadership Appointments

Jun 17, 2025, 4:05 PM EDT - 3 months ago

Applied Therapeutics Announces Key Leadership Appointments

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

May 18, 2025, 7:28 AM EDT - 4 months ago

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Applied Therapeutics Reports First Quarter 2025 Financial Results

May 13, 2025, 5:00 PM EDT - 4 months ago

Applied Therapeutics Reports First Quarter 2025 Financial Results

Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

May 9, 2025, 5:00 PM EDT - 4 months ago

Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

Mar 31, 2025, 7:10 AM EDT - 5 months ago

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

Mar 19, 2025, 7:00 AM EDT - 6 months ago

Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics

Feb 16, 2025, 9:20 AM EST - 7 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics

APLT COURT NEWS: Applied Therapeutics has been Sued for Securities Fraud; Contact BFA Law by February 18 if You Lost Money (NASDAQ:APLT)

Feb 16, 2025, 7:18 AM EST - 7 months ago

APLT COURT NEWS: Applied Therapeutics has been Sued for Securities Fraud; Contact BFA Law by February 18 if You Lost Money (NASDAQ:APLT)

APLT Deadline: Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors to Contact the Firm for Information About Their Rights

Feb 15, 2025, 2:20 PM EST - 7 months ago

APLT Deadline: Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors to Contact the Firm for Information About Their Rights

Shareholders of Applied Therapeutics, Inc. Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLT

Feb 13, 2025, 5:45 AM EST - 7 months ago

Shareholders of Applied Therapeutics, Inc. Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLT

APLT SHAREHOLDER NEWS: Applied Therapeutics Investors that Lost Money may have been affected by Fraud - Contact BFA Law by February 18 Deadline

Feb 12, 2025, 3:18 PM EST - 7 months ago

APLT SHAREHOLDER NEWS: Applied Therapeutics Investors that Lost Money may have been affected by Fraud - Contact BFA Law by February 18 Deadline

APLT DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Deadline and Encourages Investors with Losses to Contact the Firm

Feb 10, 2025, 7:00 PM EST - 7 months ago

APLT DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Deadline and Encourages Investors with Losses to Contact the Firm

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT

Feb 10, 2025, 5:45 AM EST - 7 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT

Applied Therapeutics, Inc. Is Being Sued For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

Feb 2, 2025, 11:00 AM EST - 7 months ago

Applied Therapeutics, Inc. Is Being Sued For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics

Jan 29, 2025, 10:20 AM EST - 8 months ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics

Gravy94
Gravy94 Sep. 11 at 5:06 PM
$APLT just tell me Nancy Pelosi’s husband is invested in it, and I’ll bet the house!
1 · Reply
5xStarTrader
5xStarTrader Sep. 11 at 4:13 PM
$APLT The MMs are loading up ahead of the pending FDA news, bc they know as much as we do, or more, from their “colleagues-for-hire” at the FDA, on the imminent positive news (after all, it’s not like Congress is concerned about insider trading.) So as a MM, how do you get sellers? You do it by pulling out your Bids and dropping the stock price, while blockading the Ask with unlimited counterfeit shares, in order to collect those millions of shares shares without running up the share price. Just remember, 100% of patients in the trial opted to continue taking the drug bc of their experience of significant improvements in quality of life.
1 · Reply
CAMDENBEER
CAMDENBEER Sep. 10 at 2:30 PM
$APLT you losers could own Oracle, - orcl - up $95 points today. or you can own this APLT trash. and wait for the chapter 11 and delisting.
2 · Reply
Jasko563
Jasko563 Sep. 10 at 11:40 AM
$APLT bears in this thread are weird .. 99% of them don’t short this or don’t short at all . Yet they hang around here. Like why !? brother we trade penny stocks we don’t need your financial advice . A lot of us are here to flip plays not hold for years nor should you. lol I got just enough invested in this that I don’t care if I loose once my stop loss gets hit . Now if you are shorting this then good for you let’s battle it out and see who wins short term 😊 GL to all bulls and bears & fuc* all the penny stock financial advisers , you guys are goofy
1 · Reply
Moondogshouse
Moondogshouse Sep. 9 at 8:09 PM
$APLT Just typical MM trading the past 20 trading days. Add in low 40’s sell low 50’s. Great returns. Gonna be same pattern for the next 20 days. 20 days ago 42.2. 10 days later .55. 10 days later low of .425. MM and day traders love this.
0 · Reply
CAMDENBEER
CAMDENBEER Sep. 9 at 4:59 PM
$APLT if you want to know why APLT is sinking... just look at Level 2 quotes. lots of big sell limit orders. very few bids.
1 · Reply
Pengwinn
Pengwinn Sep. 9 at 4:01 PM
$APLT This company is a real disaster
2 · Reply
Pengwinn
Pengwinn Sep. 9 at 3:55 PM
$APLT It will retest 0.29. Extremely dangerous. A triple bottom is extremely likely.
0 · Reply
DJW009
DJW009 Sep. 9 at 3:23 PM
$APLT Just playng with some numbers, AT-007 SORD-CMT could treat 7,000 (US and EU) patients annually. That is an estimated revenue of $500M (peak annually). Plus estimated another $100M for PMM2-CDG, plus some for leasing out their drug AT-001 $10M-$20M (?). That's $610M or more. With 144.01M shares outstanding, plus 75M (potentially) more = 219.1M shares outstanding. $610M/219.01 shares = 2.785 x 2.5 multiplier (2 to 4 is normal) = $6.93 per share.
2 · Reply
DJW009
DJW009 Sep. 9 at 2:27 PM
$APLT Sponsored assay for CMT-SORD was launched in July 2025 to help identify patients with CMT-SORD to treat for their drug. This shows confidence in proceeding forward with their FDA meeting.
0 · Reply
DJW009
DJW009 Sep. 9 at 2:24 PM
$APLT PMM2-CDG trail update (different drug that AT-001 or AT-007): Results from a trial for govorestat in PMM2-CDG will be presented at the ASHG Annual Meeting in October of 2025.
0 · Reply
DJW009
DJW009 Sep. 8 at 8:23 PM
$APLT Just remember, the techincals mean nothing with this stock. It's all about the news from the FDA meeting.
1 · Reply
RonRon1234
RonRon1234 Sep. 8 at 7:42 PM
$APLT stocktwits keeps showing my $9. It's foreshadowing!
0 · Reply
Cjb6685
Cjb6685 Sep. 8 at 7:38 PM
$APLT not the power hour I was thinking about
0 · Reply
CAMDENBEER
CAMDENBEER Sep. 8 at 7:02 PM
$APLT huge sell limit orders on Level 2. bids are thining out. Market Makers must know chapter 11 or delisting is coming.
0 · Reply
Pengwinn
Pengwinn Sep. 8 at 6:13 PM
$APLT bad
1 · Reply
DJW009
DJW009 Sep. 8 at 1:36 PM
$APLT Probably doing boh the US and Europe at the same time like the last time
0 · Reply
Itsnowornever
Itsnowornever Sep. 8 at 12:15 PM
$APLT Should they focus on Europe first. Considering the uncertainty about FDA leadership etc.
0 · Reply
Cjb6685
Cjb6685 Sep. 5 at 4:36 PM
$APLT shorts pushing us down.
0 · Reply
ClenchFists
ClenchFists Sep. 5 at 2:09 PM
$APLT Loading!!! So cheap!!!
0 · Reply
Itsnowornever
Itsnowornever Sep. 5 at 2:08 PM
$APLT Time to buy more It’s a risk but I think we’ll have positive news regarding FDA very shortly.
0 · Reply
Aspirinik
Aspirinik Sep. 5 at 8:43 AM
$APLT Classic shake the tree!
0 · Reply